Study: SPECT sheds light on liver function, may aid cancer treatment

02/9/2013 | MedicalXpress.com

SPECT imaging with 99mTc-labeled iminodiacetic acid before and during radiation therapy to monitor hepatic function in patients with unresectable liver cancer provides data that could allow for more personalized treatment plans, according to a study presented at an imaging and radiation therapy conference. "The physiological adaptation of radiation therapy based upon individual response assessment is a valuable new paradigm worth additional testing," said lead researcher Hesheng Wang of the University of Michigan.

View Full Article in:

MedicalXpress.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY